The Rise of Mental Health Awareness and the Booming Market for Less Invasive Solutions

In the past, mental health conditions like ADHD, bipolar disorder, and depression were rarely discussed openly. Today, these conditions are much more common, and it's not unusual to have friends or family members who are affected.

In the United States alone, the number of diagnosed cases of ADHD in children has risen dramatically, from 6% at the turn of the century to over 11% in 2023 (more than 7 million children). This trend is mirrored globally, with the mental health market exceeding €400 billion and projected to grow at a rate of 9% annually (source: Spherical Insights and Technavio).

Multiple Factors Driving the Growth of the Cognitive Health Market

Several key factors are converging to drive the growth of the cognitive health market:

• An aging population: As the population ages, there is a higher prevalence of cognitive conditions like dementia, Parkinson's disease, and Alzheimer's disease.
• Increased mental health awareness: People are becoming more aware of mental health issues and are proactively seeking solutions to improve their cognitive and emotional well-being.
• Rising diagnoses of neurological and cognitive disorders: Conditions like ADHD, depression, and bipolar disorder are being diagnosed more frequently.

Traditional Treatments and the Rise of Natural Supplements

While medications like methylphenidate, amphetamines, lithium, and benzodiazepines are commonly used to treat mental health conditions, they can have significant side effects, including dependence, toxicity, and misuse. This has led to a surge in interest in natural cognitive health supplements, a market currently estimated at $13 billion.

These new therapeutic nutraceuticals are formulated with ingredients like nootropics, adaptogens, omega-3 fatty acids, hydroxytyrosol, vitamins, minerals, probiotics, and herbal extracts.

Source: Market Research Future

Companies Leading the Charge in Cognitive Health Supplements

Several companies are actively developing and promoting cognitive health supplements. Let us review a few interesting examples:

• Thorne HealthTech: Offers a range of supplements designed to support cognitive function and protect the brain from oxidative stress.
• Quincy Bioscience: Known for its Prevagen brain health supplement, which focuses on improving memory and cognitive function in aging populations.
• Persona Nutrition: Develops personalized nutrition plans to optimize brain health, considering individual dietary needs and genetic predispositions.
• Onnit Labs: Provides a comprehensive approach to brain health with its "Total Human Optimization" system, encompassing nootropics, lifestyle strategies, and personalized coaching.
• Numedica: A leading provider of nutritional supplements that focus on supporting brain health, including memory, focus, and mood.
• Natural Factors Nutritional Products, Maypro Industries, LC Ingredients, and Kyowa Hakko Bio: Contribute to brain health by supplying high-quality ingredients and raw materials used in brain-boosting supplements.

Mergers and Acquisitions: Strong activity in the Nutraceutical Space

The fragmented nature of the cognitive health market, coupled with the ongoing trend of M&A activity in the broader nutraceutical space, anticipates an increasing number of transactions within the brain health sector. Large companies like Nestlé, Kerry, ADM, Ingredion, and DSM are actively acquiring smaller natural supplement companies to expand their portfolios of natural and innovative over-the-counter (OTC) products, of which cognitive supplements will keep gaining weight in their portfolios.

The Rise of Mental Health Apps: A Complementary Approach

Another rapidly growing non-invasive brain health segment is the market for mental health digital applications. These digital tools provide support for mental well-being and can complement traditional therapies or offer alternative solutions altogether.

Using artificial intelligence algorithms, Cognoa, founded in 2013 in Palo Alto (California), is revolutionizing the diagnosis of autism. This company has developed an early diagnostic device designed to identify signs of autism in children under the age of five, using an innovative approach based on one-minute videos that analyze the child's interaction while playing, eating, and engaging socially.

Other companies like Kintsugi, Grow Therapy, Akili Interactive, Silvercloud, Sincrolab, Neuronup, and Joon are also developing mental health apps in collaboration with mental health professionals. These apps address various cognitive functions, including memory, attention, spatial vision, and mental agility.

M&A Activity in the Mental Health App Market

Similar to the nutraceutical space, the mental health app market is also providing interesting acquisitions:

• Amwell: A prominent telehealth company acquired SilverCloud Health, a behavioral health platform, and Conversa Health, a chatbot technology company, for a combined $320 million. This acquisition allows Amwell to expand its digital mental health offerings and improve patient engagement.
• Uwill: A virtual mental health provider for college students, acquired its competitor, Virtual Care Group. This merger allows Uwill to reach a wider audience and accelerate its growth within the higher education sector.
• Ginger and Headspace: Merged to form Headspace Health, combining Ginger's on-demand mental health coaching and video therapy platform with Headspace's mindfulness and meditation app. This merger created a comprehensive digital mental health platform valued at approximately $3 billion.

In summary, while traditional medications play a role, the demand for natural and digital solutions is increasing as a means of complementary or lesser invasive therapies. The nutraceutical market is witnessing a surge in innovation and M&A activity as large companies seek to acquire smaller players with cutting-edge technologies or innovative ingredients. Similarly, the mental health app market is gaining attraction as a way for behavioral mental health companies to enhance their offerings to patients. These trends suggest a dynamic and evolving landscape for the cognitive health market, with continued innovation and growth anticipated in both the nutraceutical and digital health sectors.

CDI Global (www.cdiglobal.com), a well-established M&A network with over 50 years of experience in facilitating cross-border acquisitions, has cultivated a deep understanding of the healthcare market. Through its involvement in numerous transactions across the United States, Latin America, Asia and Europe, CDI Global has gained valuable insights into the characteristics of the nutraceutical and digital industries. If you'd like to explore potential transactions or benefit from our expertise, please feel free to reach out.

By: Carmelo de las Morenas, Managing partner of CDI Global Iberia